Neurocrine Biosciences
NBIX
#1421
Rank
A$22.00 B
Marketcap
A$218.80
Share price
0.77%
Change (1 day)
15.99%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Annual Reports

Thumbnail Neurocrine Biosciences
 Annual Report 2016

Annual Report 2016

Language: English

View Annual Report